drugset / Trial / NCT01201122
Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate effectiveness of once daily dosing of Pentasa compared with twice daily in children with mild to moderate active ulcerative colitis.
Timeline
- Start
- 2010-09
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesalamine | Small molecule | 75 mg/kg | — |
| Subject | Mesalamine | Small molecule | 500 mg | — |
| Subject | Mesalamine | Small molecule | 1000 mg | — |
| Subject | Mesalamine | Small molecule | 1500 mg | — |
| Subject | Mesalamine | Small molecule | 2000 mg | — |
| Subject | Mesalamine | Small molecule | 3000 mg | — |